Locations:
Search IconSearch
March 23, 2017/Cancer/News & Insight

New Cancer Center Houses Ohio’s Most Advanced Gamma Knife Technology

Icon one of many upgrades in new building

suh-icon_650x450

The new Taussig Cancer Center building, which opened March 6, 2017, houses Ohio’s first Leksell Gamma Knife Icon™ radiosurgery technology. Icon offers the most precise brain radiosurgery capabilities of any currently available technology.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The addition of this new technology further enhances patient care, research and education at Cleveland Clinic Cancer Center. Since 1997, the center has performed over 6000 cases using Gamma Knife for brain tumor treatment. Cleveland Clinic is also one of the few centers to offer a week-long Gamma Knife training course, which has trained hundreds of physicians and medical physicists. In addition, the center is active in scientific and clinical research, has ongoing clinical trials for patients with brain metastases and holds an annual international symposium on radiosurgery.

Upgraded features benefit patient care

Icon’s front-mounted, cone-beam CT scanner allows the physician to verify the patient’s head position prior to treatment. This verification enables physicians to treat tumors in locations close to critical structures such as the optic apparatus and brain stem, and to replace rigid frames that screw into a patient’s skull with a mask as a stereotactic reference.

The mask “offers a better patient experience for some patients and allows us to divide treatments over multiple sessions, which is useful for some complex cases,” says John Suh, MD, Chair of the Department of Radiation Oncology at Cleveland Clinic’s Taussig Cancer Center and Associate Director of the Gamma Knife Center. The presence of high-definition motion management, which uses an infrared camera, monitors any patient motion during treatment.

Icon one of many upgrades in new building

The new 377,000-square-foot, $276 million Cancer Center building is designed, top to bottom, to “optimize multidisciplinary care and patient experience and minimize wait times,” says Dr. Suh. The light-filled building extends its brightness to the lower level of the radiation treatment center with an enormous standing skylight that protrudes into the parking drop off area. “The presence of natural light into the radiation oncology department is very important. It helps make the space more open and inviting, which helps comfort patients and their families,” says Dr. Suh.

Advertisement

All radiation treatments will occur in the new Cancer Center. Six state-of-the-art linear accelerators with image guidance, two large bore CT simulators, a hyperthermia suite, a high-dose rate brachytherapy suite and MRI for simulation will join Icon in the array of radiation treatments available for Cleveland Clinic patients. In addition, the lower level will feature a large physician conference room with two 100-inch monitors.

“It’s a very exciting time in oncology, in particular radiation oncology,” says Dr. Suh. “We plan to create the future of cancer care in the new Taussig Cancer Center by providing timely, compassionate, innovative and comprehensive cancer care.”

Advertisement

Related Articles

Man touching lymph nodes
February 12, 2026/Cancer
EGFR-MET Bispecific Antibody Shows Promise for Metastatic Head & Neck Cancer

Early results show strong clinical benefit rates

Bispecific antibodies
February 10, 2026/Cancer/Blood Cancers
MajesTEC-3 Trial Outcomes May Change Course of Myeloma Treatment

The shifting role of cell therapy and steroids in the relapsed/refractory setting

Hands after RT
January 30, 2026/Cancer/Radiation Oncology
Patient Case Study: Radiation Therapy Used to Treat Dupuytren's Disease

Radiation therapy helped shrink hand nodules and improve functionality

Dr. Ali and patient
January 29, 2026/Cancer/News & Insight
Real-World Data Reveals Gap Between Guidelines and Practice in HER2+ Breast Cancer Care

Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches

Dr. Thomas Budd
January 28, 2026/Cancer/Innovations
Breast Cancer Vaccine Moves One Step Forward

Phase 1 study demonstrates immune response in three quarters of patients with triple-negative breast cancer

Dr. Mukhejee and colleagues
January 22, 2026/Cancer/News & Insight
Rare Cancers and Blood Disease Program Accelerates Diagnostic Journey

Multidisciplinary teams bring pathological and clinical expertise

genetic test
January 16, 2026/Cancer/News & Insight
Five Percent of U.S. Population Carries Pathogenic Variants Associated with Cancer Risk

Genetic variants exist irrespective of family history or other contributing factors

GLP-1
January 12, 2026/Cancer/Blood Cancers
GLP-1a Therapy Improves Survival in Patients with Polycythemia Vera and Myelodysplastic Syndromes

Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists

Ad